* Q3 sales down 1 pct at $12.1 bln, lagging poll (Recasts, adds CEO comment, analysts, background)
* Says 9-month net profit up 28.6 percent y/y at 500.5 million yuan ($73.84 million)
* Says it gets securities regulator's approval for asset acquisition, shares to resume trading on Oct 26
BRIEF-Sichuan Maccura Biotechnology to use 3 mln yuan to jointly set up medical instruments sale company
* Says it will use 3 million yuan to jointly set up a medical instruments sale company in Urumchi with three individuals
* Sees net profit for 2016 to increase by 20 percent to 30 percent, or to be 446.6 million yuan to 483.8 million yuan
No related earnings announcements are currently scheduled within the next 7 days.